section name header

Information

Fatigue is nearly a universal symptom in terminally ill pts. It is often a direct consequence of the disease process (and the cytokines produced in response to that process) and may be complicated by inanition, dehydration, anemia, infection, hypothyroidism, and drug effects. Depression may also contribute to fatigue. Functional assessments include the Karnofsky performance status or the Eastern Cooperative Oncology Group system based on how much time the pt spends in bed each day: 0, normal activity; 1, symptomatic without being bedridden; 2, in bed <50% of the day; 3, in bed >50% of the day; 4, bedbound.

Interventions Modest exercise and physical therapy may reduce muscle wasting and depression and improve mood; discontinue medications that worsen fatigue, if possible; glucocorticoids may increase energy and enhance mood; dextroamphetamine (5-10 mg/d) or methylphenidate (2.5-5 mg/d) in the morning may enhance energy levels but should be avoided at night because they may produce insomnia; modafinil and L-carnitine have shown some promise.

Outline

Section 1. Care of the Hospitalized Patient